GTCR and Cole-Parmer Announce Acquisition of ZeptoMetrix

GTCR, a leading private equity firm, announced today that its Cole-Parmer ("CP") portfolio company has acquired ZeptoMetrix Corporation ("ZeptoMetrix").  ZeptoMetrix is a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases. Founded in 1999 and headquartered in Buffalo, NY, ZeptoMetrix's products, including its patented NATtrol™ family of products, are used for nucleic acid testing within the diagnostic testing industry. These products are used regularly by clinical testing labs to verify that molecular diagnostic instruments are performing and accurately detecting the presence of specific genetic material within a patient sample. The ZeptoMetrix product portfolio is focused on infectious disease, including gastrointestinal, women's health, hospital acquired infections, and respiratory, including the flu, RSV and Covid, among others.  The acquisition of ZeptoMetrix expands CP's quality controls and reference standards portfolio and further establishes CP as a leading manufacturer of specialty chemistries and reagents for life sciences research and diagnostic testing. The acquisition represents CP's second acquisition in the past year and 12th since 2014. About Cole-ParmerFounded in 1955, Cole-Parmer® is a leading global manufacturer of proprietary products for fluidics, critical research and process equipment and specialty chemicals for life sciences, environmental sampling and analysis, analytics and essential lab supplies. We are proven experts in the fields of fluid handling, environmental testing, cold chain storage and monitoring, sample preparation & handling and chromatography. Our instruments and consumables have been used extensively in the biopharma research and production, pharmaceutical, life sciences, environmental, and the food and beverage industries for over 65 years. For more information, please visit www.coleparmer.com About ZeptoMetrixZeptoMetrix Corporation is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Founded in 1999, the company's expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and made ZeptoMetrix the preferred choice for independent 3rd party quality control materials. ZeptoMetrix's patented NATtrolTM process renders highly-purified microorganisms non-infectious while allowing internal nucleic acids to remain intact, thereby serving as an ideal reference material for molecular diagnostic testing applications. Representing a total process control, from DNA extraction through amplification and eventual detection, NATtrolTM products are ready-to-use, refrigerator stable, and safe for operators to handle. For more information, please visit www.zeptometrix.com
（以上内容由医药魔方AI生成）